Nelly F.
- Country
- France
- Department
- Medical oncology
Research Overview
- Phase I Evaluation of MEDI5752 Combined with Stereotactic Radiotherapy in Metastatic Soft Tissue Sarcoma Patients
- Phase 2 Multicentre Randomized Trial of Mifamurtide with Post-Operative Chemotherapy in High-Risk Osteosarcoma Patients
- Evaluation of Perioperative Doxorubicin, Ifosfamide, and Dacarbazine in CINSARC High-Risk Localized Soft Tissue Sarcoma Patients
Data & Insights
Has run more than one trial at 100 of 313 partner sites.
Specializations
Bone and Soft Tissue Sarcomas
The investigator specializes in treating various forms of bone sarcomas and soft tissue sarcomas, with particular expertise in managing conventional chondrosarcoma and osteosarcoma.
- High-risk osteosarcoma management
- Metastatic bone sarcoma treatment
- Unresectable chondrosarcoma care
- Maintenance therapy approaches
The investigator focuses on integrating novel therapeutic agents with standard treatment protocols for bone and soft tissue malignancies.
Breast Cancer Treatment
Extensive experience in treating various subtypes of breast cancer, particularly focusing on triple-negative breast cancer (TNBC) and hormone receptor-positive/HER2-negative disease.
- Metastatic breast cancer therapies
- Advanced hormone-positive disease
- Novel therapeutic combinations
- High-risk disease management
Specializes in developing treatment strategies for patients with locally advanced and metastatic breast cancer.
Advanced Therapeutic Approaches
Focuses on innovative treatment modalities including immunotherapy combinations and targeted therapies for various solid tumors.
- Combination therapy development
- Perioperative treatment strategies
- Maintenance therapy protocols
- Risk-adapted treatment approaches
Implements personalized treatment strategies based on molecular and clinical risk factors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.